Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$162.77 USD

162.77
960,238

+0.07 (0.04%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $162.84 +0.07 (0.04%) 5:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 15% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Clorox (CLX) Surpasses Earnings & Sales Estimates in Q4

by Zacks Equity Research

Clorox's (CLX) Q4 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and inflation.

Clorox (CLX) Reports Q4 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clorox (CLX) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Clorox (CLX) delivered earnings and revenue surprises of 40.34% and 7.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's What Awaits Clorox (CLX) When It Reports Q4 Earnings

by Zacks Equity Research

Clorox's (CLX) Q4 results are expected to reflect gains from solid demand trends, pricing actions, digital investments, cost-saving efforts and the IGNITE strategy.

Church & Dwight (CHD) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Church & Dwight (CHD) delivered earnings and revenue surprises of 16.46% and 2.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Factors to Note Ahead of Sysco Corporation's (SYY) Q4 Earnings

by Zacks Equity Research

Sysco's (SYY) fiscal fourth-quarter earnings is likely to reflect gains from the Recipe for Growth initiative. However, rising cost inflation might have been a hurdle.

Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.

Clorox (CLX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clorox (CLX) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Clorox (CLX) closed the most recent trading day at $153.01, moving -1.39% from the previous trading session.

Will Clorox (CLX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Is Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.

Clorox (CLX) Gains From Digital Initiatives & Pricing Power

by Zacks Equity Research

Clorox's (CLX) IGNITE strategy serves as a catalyst for driving innovation, enhancing operational efficiency and bolstering international growth.

Procter & Gamble (PG) Widens Spectrum on Value Creation

by Zacks Equity Research

Procter & Gamble (PG) advances the execution of the integrated strategies -- Supply Chain initiatives and digital penetration to strengthen the organization.

Church & Dwight (CHD) Shares Up 21.9% YTD: What's Driving It?

by Zacks Equity Research

Church & Dwight (CHD) gains from its strength across end markets, acquired assets, its solid online channel and shareholder-friendly policies.

Zacks Investment Ideas feature highlights: Lamb Weston, Coca-Cola and Clorox

by Zacks Equity Research

Lamb Weston, Coca-Cola and Clorox are part of the Zacks Investment Ideas article.

Derek Lewis headshot

3 Stocks Tailored Toward a Defensive Approach

by Derek Lewis

These companies' products have an advantageous ability to generate consistent demand in the face of many economic situations. And recently, analysts have become optimistic surrounding their outlooks.

Helen of Troy (HELE) Readies for Q1 Earnings: Things to Note

by Zacks Equity Research

Helen of Troy's (HELE) first-quarter results are likely to reflect the impacts of a tough operating landscape, including volatile consumer spending, while a focus on Project Pegasus bodes well.

Why You Must Consider Colgate (CL) Stock Before Q2 Earnings

by Zacks Equity Research

Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.

Best Growth Stocks to Buy for June 30th

by Zacks Equity Research

AMWD, CLX and TOL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2023.

Clorox (CLX) Surpasses the Industry in a Year: Here's How

by Zacks Equity Research

Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.

Best Growth Stocks to Buy for June 27th

by Zacks Equity Research

BEKE, CLX and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 27, 2023.

Nalak Das headshot

Top 5 Dividend-Paying Low-Beta Stocks Amid Recent Volatility

by Nalak Das

We have narrowed our search to five dividend-paying low-beta stocks. These are: CLX, GGG, MLM, VMC, KNSL.

Brian Bolan headshot

Bull Of The Day: Clorox (CLX)

by Brian Bolan

This is more of an earning growth story than a revenue growth story.

What Makes Clorox (CLX) a New Strong Buy Stock

by Zacks Equity Research

Clorox (CLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Best Income Stocks to Buy for June 23rd

by Zacks Equity Research

CLX, GEF and KMT made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 23, 2023.